https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/pdf/210_2016_Article_1247.pdf
Zeitpunkt der Veröffentlichung
2016
How to cite
Molderings, Gerhard & Haenisch, Britta & Brettner, Stefan & Homann, Jürgen & Menzen, Markus & Ludwig Dumoulin, Franz & Panse, Jens & Butterfield, Joseph & Afrin, Lawrence. (2016). Pharmacological treatment options for mast cell activation disease. Naunyn-Schmiedeberg's Archives of Pharmacology. 389. 10.1007/s00210-016-1247-1.
Zitat im Text (APA)
Molderings et al., 2016
Land
Deutschland, USA
beteiligte Kliniken
Institute of Human Genetics, University Hospital of Bonn, Bonn, Germany, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany, Department of Oncology, Hematology and Palliative Care, Kreiskrankenhaus Waldbröl, Waldbröl, Germany, Allgemeine Innere Medizin, Gastroenterologie und Diabetologie, Gemeinschaftskrankenhaus, Bonn, Germany, Department of Hematology, Oncology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany, Program for the Study of Mast Cell and Eosinophil Disorders, Mayo Clinic, Rochester, MN, USA, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN, USA
Article Identifier
doi: 10.1007/s00210-016-1247-1
Corresponding Author
Diese E-Mail-Adresse ist vor Spambots geschützt! Zur Anzeige muss JavaScript eingeschaltet sein!
Sprache
englisch
Dateiname
M03_Pharmacological_treatment_options_for_mast_cell_activation_disease